Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease

Published:2013-02 Issue:2 Volume:15 Page:123-131
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Banugaria Suhrad G.,Prater Sean N.,McGann Judeth K.,Feldman Jonathan D.,Tannenbaum Jesse A.,Bailey Carrie,Gera Renuka,Conway Robert L.,Viskochil David,Kobori Joyce A.,Rosenberg Amy S.,Kishnani Priya S.

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/gim2012110.pdf

Reference39 articles.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical pharmacology considerations for first‐in‐human clinical trials for enzyme replacement therapy;Journal of Inherited Metabolic Disease;2024-05-13

2. Advances in Immune Tolerance Induction in Enzyme Replacement Therapy;Pediatric Drugs;2024-04-25

3. Optimizing treatment outcomes: immune tolerance induction in Pompe disease patients undergoing enzyme replacement therapy;Frontiers in Immunology;2024-04-23

4. An updated management approach of Pompe disease patients with high-sustained anti-rhGAA IgG antibody titers: experience with bortezomib-based immunomodulation;Frontiers in Immunology;2024-03-08

5. Preclinical studies with ground germinated barley (GGB) for oral enzyme replacement therapy (Oral-ERT) in Pompe disease knockout mice;2023-12-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP